Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2026-03-06 @ 2:31 PM
Study NCT ID:
NCT02056392
Status:
COMPLETED
Last Update Posted:
2015-11-09
First Post:
2014-02-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers
Sponsor:
AstraZeneca
Organization: